Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

7.62
Delayed Data
As of May 23
 +0.13 / +1.74%
Today’s Change
4.60
Today|||52-Week Range
8.63
+28.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash119.3M74.1M140.6M90.6M
 
 
 
 
 
Short Term Investment Cash53.4M-45.2M64.8M-48.3M
 
 
 
 
 
Cash & Short Term Investments119.3M74.1M140.6M90.6M
 
 
 
 
 
 
ReceivablesReceivables109.0K3.5M4.9M4.0M
 
 
 
 
 
 
InventoriesInventories--0.000.000.00--
 
Current AssetsOther Current Assets2.5M5.6M2.6M2.3M
 
 
 
 
 
Current Assets121.9M83.3M148.1M96.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross12.4M12.7M5.6M5.8M
 
 
 
 
 
Depreciation-9.8M-10.3M-838.0K-1.7M
 
 
 
 
 
Intangible Assets36.4M43.9M43.7M43.4M
 
 
 
 
 
Other Assets36.6M43.9M44.1M45.0M
 
 
 
 
 
Total Assets161.0M131.3M199.0M148.1M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.0M452.0K567.0K3.4M
 
 
 
 
 
Short Term Debt0.000.000.002.4M
 
 
Accrued Expenses3.8M7.2M13.8M7.2M
 
 
 
 
 
Other Current Liabilities3.9M7.4M13.8M7.2M
 
 
 
 
 
Other Liabilities6.7M9.7M16.4M15.4M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.0049.5M47.2M
 
 
 
Deferred Taxes-11.3M-11.2M-13.0M-1.6M
 
 
 
 
 
Other Liabilities17.2M862.0K1.2M1.5M
 
 
 
 
 
Total Liabilities36.1M40.6M94.2M82.5M
 
 
 
 
 
 
EquityMinority Interest0.00-7.0K-73.0K0.00
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity124.9M90.5M104.8M65.6M
 
 
 
 
 
Total Shareholder Equity124.9M90.5M104.8M65.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding69.6M69.9M70.2M71.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.